Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2021-03-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (CB) issued by FutureChem. It details the number of shares issued upon conversion, the adjustment of the conversion price, and the remaining balance of the convertible bonds. This type of filing relates to changes in capital structure and share issuance resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2021-03-04 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees/executives, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding share-based compensation and capital changes falls under the category of regulatory filings that do not fit into specific categories like M&A or dividends, and is best classified as a general regulatory filing.
2021-03-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule report). It details the shareholding changes of Brain Asset Management Co., Ltd. in the company FutureChem. This document type is specifically designed to notify the market of significant changes in share ownership levels, which aligns with the 'Major Shareholding Notification' category.
2021-02-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (FutureChem) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for publicly traded companies in Korea (DART system) when financial results deviate significantly from the previous period. Since it provides key financial highlights and reasons for the change rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of an Earnings Release (ER) as it serves as the initial announcement of financial performance. FY 2020
2021-01-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). It details the shareholding changes of a specific director (Jung June-Key) of FutureChem, including the date of transaction and the number of shares sold. This type of filing is categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2021-01-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by a major shareholder (NAU Growth Capital Private Equity Fund) in a listed company (FutureChem). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.